Crohn's disease trials in South Korea

30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

  Where

  Seoul

  Age

  19 years to 80 years

  People

  86

  Run by

  Asan Medical Center

  See details and how to joinNCT06051253
• No phaseTaking people
  Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD

  Where

  Seoul

  Age

  18 years to 100 years

  People

  100

  Run by

  Asan Medical Center

  See details and how to joinNCT06064864
• No phaseTaking people
  A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

  Where

  Seoul

  Age

  18 years to 65 years

  People

  9

  Run by

  Anterogen Co., Ltd.

  See details and how to joinNCT03183661
• No phaseTaking people
  Gut Microbiome in Inflammatory Bowel Disease

  Where

  Seoul

  People

  1,500

  Run by

  Kyunghee University Medical Center

  See details and how to joinNCT03589183
• No phaseTaking people
  Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.

  Where

  Seoul

  People

  2,000

  Run by

  Asan Medical Center

  See details and how to joinNCT01731665